Antisense compounds compositions and methods are provided for modulating the expression of SMRT. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding SMRT. Methods of using these compounds for modulation of SMRT expression and for treatment of diseases associated with expression of SMRT are provided.
申请公布号
WO03106645(A3)
申请公布日期
2005.01.13
申请号
WO2003US18923
申请日期
2003.06.17
申请人
ISIS PHARMACEUTICALS, INC.;BENNETT, CLARENCE, FRANK;FREIER, SUSAN, M.;DOBIE, KENNETH, W.
发明人
BENNETT, CLARENCE, FRANK;FREIER, SUSAN, M.;DOBIE, KENNETH, W.
